Clopidogrel usually refers to clopidogrel bisulfate tablets. Clopidogrel bisulfate is not recommended to be taken at the same time as Dipyridamole tablets. 1. Clopidogrel bisulfate and dipyridamole tablets both belong to the antiplatelet aggregation class of drugs. Clopidogrel is more commonly used in patients with recent myocardial infarction, patients with recent ischemic stroke, or patients with confirmed peripheral arterial disease. Dipyridamole is mainly used to prevent thrombosis. 2. Clopidogrel bisulfate tablets may cause thrombocytopenia, immune system abnormalities, neurological abnormalities and other adverse reactions during administration. Adverse effects are mild and transient at therapeutic doses of dipyridamole tablets, and the initial side effects tend to disappear with prolonged administration. Common symptoms may manifest as dizziness, nausea, vomiting, etc. Adverse reactions that persist or are not tolerated are rare and may disappear after discontinuation of the drug. 3. Clopidogrel is contraindicated in patients who are hypersensitive to the active substance or to any abnormality of the product, in patients with severe liver damage, and in patients with peptic ulcer. Contraindications to dipyridamole: it is contraindicated in hypersensitivity. The combined use of the drug with anticoagulants, antiplatelet aggregating agents and thrombolytics requires attention to bleeding tendencies. When treating with clopidogrel bisulfate tablets, it is not recommended to take dipyridamole tablets at the same time, because both drugs are antiplatelet aggregating drugs. The period of treatment needs to be combined with the condition of the body, and it is usually enough to take one of them. When using the drug treatment must strictly follow the doctor’s instructions, if the body has serious adverse reactions, you need to stop using the drug and go to the hospital for medical treatment.